中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Science
Anti-viral Platform
RNA Interference
Fatty Liver Disease
Products & Pipeline
Overview
HCV
HBV
HIV
Partnership
Investors
Financials & Filing
Presentation Materials
News
2020
2019
2018
2017
2016
2015
2014
Careers
Investors
Financials & Filing
Presentation Materials
Notice of 2020 Annual General Meeting
2020-05-13
Proposals for General Mandates to Issue Shares and to Repurchase Shares, Re-election of Retiring Directors and Notice of Annual General Meeting
2020-05-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
2020-05-06
Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Annual Report 2019
2020-04-22
Annual Report 2019
2020-04-22
Voluntary Announcement - IND Approval of ASC09/Ritonavir Fixed-dose Combination
2020-04-13
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
2020-04-02
Voluntary Announcement - Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
2020-04-01
Grant of Share Options
2020-03-31
2019 Annual Results
2020-03-24
«
3
4
5
6
»
